Clene Inc has a consensus price target of $7 based on the ratings of 7 analysts. The high is $10 issued by Roth MKM on August 29, 2023. The low is $4 issued by Cantor Fitzgerald on August 16, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 21, 2024, June 18, 2024, and May 28, 2024, respectively. With an average price target of $7 between HC Wainwright & Co., there's an implied 54.53% upside for Clene Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/21/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
06/18/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
05/28/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
05/23/2024 | Buy Now | 10.38% | Benchmark | Bruce Jackson | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
04/17/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
03/20/2024 | Buy Now | 10.38% | Benchmark | Bruce Jackson | → $100 | Reiterates | Buy → Buy | Get Alert |
03/13/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | → $140 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Maintains | Buy | Get Alert |
02/22/2024 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | → $140 | Reiterates | Buy → Buy | Get Alert |
12/21/2023 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | → $140 | Reiterates | Buy → Buy | Get Alert |
09/21/2023 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | → $140 | Reiterates | Buy → Buy | Get Alert |
08/29/2023 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | → $140 | Reiterates | Buy → Buy | Get Alert |
08/29/2023 | Buy Now | 120.75% | Roth MKM | Jonathan Aschoff | → $200 | Reiterates | Buy → Buy | Get Alert |
08/16/2023 | Buy Now | -11.7% | Cantor Fitzgerald | Charles Duncan | → $80 | Reiterates | Overweight → Overweight | Get Alert |
08/14/2023 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
06/30/2023 | Buy Now | 10.38% | Benchmark | Bruce Jackson | $140 → $100 | Maintains | Buy | Get Alert |
06/21/2023 | Buy Now | 54.53% | HC Wainwright & Co. | Joseph Pantginis | $300 → $140 | Maintains | Buy | Get Alert |
06/20/2023 | Buy Now | 120.75% | EF Hutton | Elemer Piros | $260 → $200 | Maintains | Buy | Get Alert |
06/16/2023 | Buy Now | 54.53% | Benchmark | Bruce Jackson | → $140 | Reiterates | Buy → Buy | Get Alert |
05/25/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | Buy → Buy | Get Alert |
05/16/2023 | Buy Now | -11.7% | Cantor Fitzgerald | Charles Duncan | $100 → $80 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
04/10/2023 | Buy Now | 54.53% | Benchmark | Bruce Jackson | $220 → $140 | Maintains | Buy | Get Alert |
03/23/2023 | Buy Now | 186.98% | EF Hutton | Elemer Piros | → $260 | Reiterates | → Buy | Get Alert |
03/13/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
03/13/2023 | Buy Now | 186.98% | EF Hutton | Elemer Piros | → $260 | Reiterates | → Buy | Get Alert |
03/10/2023 | Buy Now | 76.6% | Cantor Fitzgerald | Charles Duncan | $120 → $160 | Maintains | Buy | Get Alert |
03/09/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
03/09/2023 | Buy Now | 186.98% | EF Hutton | Elemer Piros | → $260 | Reiterates | → Buy | Get Alert |
03/08/2023 | Buy Now | 186.98% | EF Hutton | Elemer Piros | → $260 | Initiates | → Buy | Get Alert |
03/07/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
02/28/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
02/13/2023 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | → $300 | Reiterates | → Buy | Get Alert |
11/04/2022 | Buy Now | 231.13% | HC Wainwright & Co. | Joseph Pantginis | $320 → $300 | Maintains | Buy | Get Alert |
10/04/2022 | Buy Now | — | Oppenheimer | Leland Gershell | — | Downgrade | Outperform → Perform | Get Alert |
10/04/2022 | Buy Now | 32.45% | Canaccord Genuity | Sumant Kulkarni | $200 → $120 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | 253.2% | HC Wainwright & Co. | Joseph Pantginis | → $320 | Initiates | → Buy | Get Alert |
05/02/2022 | Buy Now | 120.75% | Canaccord Genuity | Sumant Kulkarni | → $200 | Initiates | → Buy | Get Alert |
04/11/2022 | Buy Now | 120.75% | Cantor Fitzgerald | Charles Duncan | → $200 | Maintains | Overweight | Get Alert |
The latest price target for Clene (NASDAQ:CLNN) was reported by HC Wainwright & Co. on June 21, 2024. The analyst firm set a price target for $7.00 expecting CLNN to rise to within 12 months (a possible 54.53% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Clene (NASDAQ:CLNN) was provided by HC Wainwright & Co., and Clene reiterated their buy rating.
There is no last upgrade for Clene
The last downgrade for Clene Inc happened on October 4, 2022 when Oppenheimer changed their price target from N/A to N/A for Clene Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clene was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
While ratings are subjective and will change, the latest Clene (CLNN) rating was a reiterated with a price target of $7.00 to $7.00. The current price Clene (CLNN) is trading at is $4.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.